ELEV
Asset Logo

Elevation Oncology Inc

πŸ‡ΊπŸ‡Έ NYSE/NASDAQ

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-26.23%
Annual Growth

4 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Elevation Oncology, Inc. is an oncology company. The Company is focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. Its lead product candidate, EO-3021 is an antibody-drug conjugate (ADC) designed to target Claudin 18.2, which can selectively deliver a cytotoxic payload directly to cancer cells expressing Claudin 18.2. EO-3021 consists of a fully human immunoglobulin G1 (IgG1) mAb that targets Claudin 18.2 and is site-specifically conjugated to the monomethyl auristatin E (MMAE) payload via a cleavable linker with a drug-to-antibody ratio (DAR) of 2. EO-3021 is designed to bind to Claudin 18.2 on the cell surface and is internalized, upon which the linker is cleaved in the lysosome to release the MMAE payload, a potent anti-mitotic agent. Its second program is an ADC designed to target HER3, which is overexpressed across solid tumors.

πŸ“ˆ Performance

Price History*

-93.37%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.79

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in ELEV

1

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

21 weeks

πŸ’΅ Average investment amount

$100

⏰ Last time a customer invested in ELEV

45 days
ELEV investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

100%
πŸ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in ELEV also invest in...

Adicet Bio, Inc.

ACET

πŸ™Œ Performance (5Yr p.a)

-18.28%

πŸ“Š Share price

$0.91 USD
Find Out More

πŸ™Œ Performance (5Yr p.a)

-12.74%

πŸ“Š Share price

$81.69 USD

πŸ™Œ Performance (5Yr p.a)

-19.46%

πŸ“Š Share price

$0.52 USD

πŸ™Œ Performance (5Yr p.a)

-13.59%

πŸ“Š Share price

$1.80 USD

πŸ™Œ Performance (5Yr p.a)

-18.87%

πŸ“Š Share price

$0.85 USD

Want more shares? Try these...

πŸ™Œ Performance (5Yr p.a)

158.64%

πŸ“Š Share price

$131.48 USD

πŸ™Œ Performance (5Yr p.a)

-14.24%

πŸ“Š Share price

$3.71 USD
Compare
Add to watchlist